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Diametric analysis is the standard approach utilized for tumor measurement on medical imaging. However, the availability of
newer more sophisticated techniques may prove advantageous. An evaluation of diameter, area, and volume was performed on
64 different lung lesions by three trained users. These calculations were obtained using a free DICOM viewer and standardized
measuring procedures.Measurement variability was then studied using relative standard deviation (RSD) and intraclass correlation.
Volumetric measurements were shown to bemore precise than diametric.Withminimal RSD and variance between different users,
volumetric analysis was demonstrated as a reliable measurement technique. Additionally, the diameters were used to calculate an
estimated area and volume; thereafter the estimated area and volumewere compared against the actual measured values.The results
in this study showed independence of the estimated and actual values. Estimated area deviated an average of 43.5% from the actual
measured, and volume deviated 88.03%.The range of this variancewaswidely scattered andwithout trend.These results suggest that
diametric measurements cannot be reliably correlated to actual tumor size. Access to appropriate software capable of producing
volume measurements has improved drastically and shows great potential in the clinical assessment of tumors. Its applicability
merits further consideration.
1. Introduction
Measurement of tumor size is a critical factor in determining
treatment options and monitoring treatment response. The
American Joint Committee on Cancer staging system par-
tially relies on the measured size of the primary tumor [1].
Choice of treatment and prognosis are then made based on
the data received. Response to treatment is usually measured
by reduction in the size of tumor or by necrosis. Two
primary measures of tumor burden have been employed
to determine prognosis and treatment: the World Health
Organization (WHO) criteria and the Revised Response
Evaluation Criteria in Solid Tumors (RECIST) [2, 3]. The
WHO criteria utilize a maximum axial tumor diameter and
its longest perpendicular diameter. The RECIST criteria rely
on unidimensional measurement of the longest diameter
(LD) [3].
Following treatment initiation, tumor response using
revised RECIST criteria is then delineated into complete
response (resolution of all known disease), partial response
(reduction >30% of RECIST score), progressive disease
(increase >20% of RECIST score), and stable disease (lack of
partial response or progression).
Bearing in mind that treatment options and clinical
decisions are based on these measurements, the importance
of accuracy is vital. However, the objective and accurate
measurement of tumors can be quite challenging. Figure 1
highlights the primary challenge: tumors have abstract geom-
etry. They vary in size, dimension, homogeneity, spiculation,
density, and etcetera. These variances are not uncommon.
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Figure 1:Depiction of abstract tumormorphology, four unique lung
lesions.
With this forethought, the problem becomes apparent: can
complex three-dimensional structures truly be assessed with
traditional diametric techniques?
The purpose of this study was threefold. First, inves-
tigate the viability of volumetric measurement analysis, as
compared to the standard diametric technique. Accordingly,
the evaluation of measurement variability and practicality
were paramount. The methods were designed to reflect that
focus. A free and easily accessible software application was
used to measure area and volume of solitary lung tumors,
highlighting the ease and speed at which measurements can
be taken. A relatively large sample size was used to com-
pare interobserver variability amongst differentmeasurement
techniques. Second, determine whether diametric measure-
ments can provide reliable tumor assessment. Third, propose
future considerations to delineate measurement techniques,
and improve clinical tumor assessment.
2. Materials and Methods
2.1. Patient Selection. Following Institutional Review Board
approval from SanfordMedical Center, medical record num-
bers of all male and female patients who presented with
radiologic evidence of lung cancer between 2000 and 2013
were obtained.The ICD-9 codes used in this study were 162.3
(malignant neoplasm of upper lobe bronchus or lung), 162.4
(malignant neoplasm of middle lobe bronchus or lung), and
162.5 (malignant neoplasm of lower lobe bronchus or lung).
Of the patients surveyed, the first 24 patients with
measurable lesions were identified. Lesions within the lung
parenchyma were selected in a nondiscriminatory fashion;
this allowed realistic size and morphology variation to
be represented in the data. As such, the applicability of
volumetric measurement analysis was tested over a wide
range of conditions. With regard to the 64 unique lesions
evaluated with volumetric measurements, the average size
was 5.37 cm3, with a range of 0.19 cm3 to 63.89 cm3. Following
anonymization of patient data, computerized tomography
Figure 2: Depiction of a perimetric selection used to calculate the
volume of a left lower lobe pulmonary nodule.
(CT) scans of these patients were then obtained from PACS
and downloaded onto secured personal workstations.
2.2. Software Utilization. TheDICOMviewer utilized for this
studywasOsiriX 32-bit open source version [4]. Additionally,
there is a version that is FDA approved as a Class II Medical
Device and certified as a EuropeanCEClass IIa for diagnostic
imaging in medicine, which is available for a nominal price.
2.3. Procedure Standardization. For this study, three evalu-
ators, Aaron Frenette, Joshua Morrell, and Kirk Bjella, were
trained by a licensed radiologist with the goal of standardiz-
ing program usage and tumor border identification. During
this training session, each user measured the diameter, area,
and volume of the lesions under supervision to ensure similar
measurement criteria were being met. It was agreed that
while making measurements all evaluators would utilize the
standard pulmonary window/level and proceed unrushed
with attention to detail. These measurement standards were
kept consistent throughout the entire study for all methods
performed.
Following the training, each reader independently mea-
sured 64 unique lesions on 52 different CT scans using 3mm
slices with either axial or coronal section from 24 patients.
Diameter, area, and volume measurement for each lesion
were obtained. Diameter measurements were obtained by
subjectively identifying the cross section with the longest
diameter, followed by measuring the perceived longest diam-
eterwithin that cross section using the “length” tool.The same
cross section was used to calculate the area by outlining the
perimeter of the lesion with the “closed polygon” tool. To
calculate the volume of the lesion, the area was calculated for
each cross section in which the tumor was present (Figure 2).
Upon completion, “compute volume. . .” under the ROImenu
was selected to calculate the lesion’s volume.
2.4. Statistical Analysis. Measurements were recorded, com-
bined, and analyzed in a spreadsheet (Microsoft Excel: Mac
2011 V14.1.0). The relative standard deviation (RSD) was
calculated independently for diameter, area, and volume for
each unique lesion. The RSD data was then averaged inde-
pendently for diameter, area, and volume.
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Figure 3: Depiction of poor diameter to size correlation.
For each independent lesion, the diametric data was
used to create an estimate of actual tumor size. Both area
and volume were estimated and modeled as a circle and
sphere, respectively. The appropriate mathematical relation-
ships were applied:𝐴 = 𝜋∗(0.5∗𝑑)2 and𝑉 = (4/3)∗𝜋∗(0.5∗
𝑑)
3. The approximated tumor size was then compared to the
true tumor size, per volumetric measurements. RSD analysis
was again applied to the estimated areas and volumes.
Analysis of variance (ANOVA) testing was applied
to compare estimated area/volume to known measured
area/volume. Additional data analysis was performed using
SPSS, version 21 (SPSS Inc., Chicago, IL, USA). This software
was used to quantify interobserver agreement and data
reproducibility using intraclass correlation coefficient with
95% confidence intervals [5].
An internal evaluation of the software’s volume calcu-
lation was carried out. This was performed by making a
ballistics gel mold and suspending four clay objects. Their
sizes and shapes were kept comparable to the study’s lung
lesions. A CT scan with 3mm slices of the mold was
obtained. Volumetric analysis was performed via OsiriX [6].
To determine the exact volume, the clay objects were again
measured individually using water displacement. A small
container was overfilled with water, allowing drainage via
a runoff spout. The water level was allowed to equilibrate,
so that any additional volume would cause drainage. The
clay molds were carefully submerged. Water drained equal to
the volume of the submerged object and was collected. The
drainage was weighed to the nearest one-hundredth gram.
The weight was then converted to volume, assuming water
density of 1 g/mL. Finally, the software-measured volumes
were compared against water displacement volumes.
3. Results
In the 64 independent CT imaged tumors, the RSD was
lower in the areametric and volumetricmeasurements (3.95%
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(4.65%). Diametric, areametric, and volumetric measure-
ments all allowed for similarly low RSD. Estimated tumor
dimensions, as compared to actual measured dimensions,
showed considerably greater standard deviation of 9.31% for
area and 13.95% for volume (Table 1).
The estimated tumor dimensions demonstrated substan-
tial variance from actual measured dimensions. On aver-
age, there was an 88.03% variance between the estimated
and actual measured volumes. Variance was independent
of tumor size and the range of this data was widely scat-
tered, meaning no trend exists within the variance. (Table 2,
Figure 4).These results suggest that diametric measurements
cannot be correlated to actual tumor size. Figure 3 rep-
resents one such example from the data. Figure 3(a) has
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Table 2: Average percent variance of estimated volume from
measured volume.
Variance Range Chi2 𝑝
Areametric 43.50% 4.74%–221.76% 0.31 0.58
Volumetric 88.03% 3.10%–535.40% 0 1








Diametric, single .979 .969 .987
Diametric, average .993 .989 .996
Areametric, single .998 .997 .999
Areametric, average .999 .999 1.000
Volumetric, single .999 .999 1.000
Volumetric, average 1.000 1.000 1.000
a diameter of 3.73 cm and a volume of 5.14 cm3. Figure 3(b)
has a diameter of 3.25 cm and a volume of 14.56 cm3.
While these two independent lesions have similar diameters
(Figure 3(a) > Figure 3(b) by 15%), their volumes diverge
greatly (Figure 3(b) > Figure 3(a) by 183%). Image A also
emphasizes the difficult task of consistent and objective
placement of the diameter measurement.
Intraclass correlation coefficients (ICC) were calculated
to assess interobserver reliability and reproducibility of
the study. Different measurement techniques represent the
“classes” in this study. The ICC calculates variance between
different judges and compares that variance to total vari-
ance. ICC results were interpreted according to the fol-
lowing criteria: 0.00–0.20 slight reproducibility, 0.21–0.40
fair reproducibility, 0.41–0.60moderate reproducibility, 0.61–
0.80 substantial reproducibility, and >0.80 almost perfect
reproducibility [7]. When scrutinizing the measurements of
three different judges across 64 independent CT imaged
tumors, the ICC verified minimal variance during the study.
This was true for diametric, areametric, and volumetric
measurements (Table 3).
The internal evaluation of the software’s volume calcula-
tions using four clay test objects yielded an average deviation
of 2.7% with a range of 0.297–6.692%. This mean deviation
was less than that of the interobserver variability, which was
4.04%, indicating that the software is acceptably accurate at
calculating true tumor volumes for this study.
4. Discussion
During the revision RECIST guidelines in 2009, volumetric
analysis was not recommended, citing “lack of sufficient
standardization and widespread availability” [3]. Our results
argue otherwise. As used in this study, computer software
capable of efficiently performing volumetric analysis is both
economical and readily available. Diametric, areametric, and
volumetric measurements were all shown to be reproducible,
with high intraclass correlation coefficients and low relative
standard deviation (Tables 3 and 1). Volumetric analysis did
slightly outperform the other two techniques. This outcome
alone does not necessarily support superiority but rather
establishes viability. Vetted against conventional diametric
methods, volumetric analysis was confirmed as a reliable
measurement technique; standardization is undoubtedly
achievable.
Diametric measurements lack accuracy and reliability
in assessment of tumor size. Variance was both substantial
(88.03% average) and unpredictable (3.10%–535.40% range,
no association with tumor size). RSD values were also
notably larger. The obvious opposing argument to this data
is that tumors are not well represented as spheres, so why
use spherical estimation? While the relationship may be
imperfect, it was deemed acceptable for several reasons. The
leap from tumor diameter to size occurs frequently in clinical
medicine (e.g., RECIST criteria). To study this association,
some type of objective scaling must be incorporated.Though
a sphere is a reasonable choice, it must be understood that
any model will create some degree of variance (inversely
proportional to its accuracy). Hence, the trend in variance
becomes arguably more important than average variance. If
tumor diameter is truly statistically correlated with size, a
variance trend will exist regardless of the chosen geometric
model. Our results clearly demonstrate the absence of said
trend. This finding is quite disconcerting with regard to
its clinical implications. Simple diametric measurements are
very limited in utility yet used almost exclusively. While the
information they provide is minimal, the measurements are
used for tumor assessment, which directly impacts clinical
decisions. If diameter is statistically independent of tumor
size, is our reliance on its use acceptable?
RECIST criteria are currently considered as the method
of choice in assessing the response of a tumor to treatment.
However, studies have shown discrepancies following review
of investigators with secondary panels [8]. This discordance
has been shown to be due to manual measurement variabil-
ity [9, 10]. In some studies the measurement inaccuracies
were able to account for 45% of misclassifications of tumor
response [11]. In head to head studies between the two
currently used methods, the RECIST and WHO criteria,
discrepancies have ranged between 18 and 47% [8]. This
variability was due to differences in the location, size, and
shape of the tumors.
As shown, additional discrepancies exist between the
measurement techniques themselves, which may worsen
the inaccuracies of criteria classification. This reasoning is
supported by other research, with one study concluding only
“fair to poor agreement in treatment response classification”
among different measurement techniques [12].
Volumetric analysis of growth rates has been reported to
be helpful in differentiating between benign and malignant
lesions [13]. Some small population studies have demon-
strated an advantage with automated volumetric analysis [8].
Many studies have shown a reduction of interobserver vari-
ability with the use of computer-assisted volume measure-
ments [14]. Importantly, computer-assisted measurements
allow for more reproducible results when compared to
other measurement techniques [13, 15]. It has been shown
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that volume measurements may allow earlier recognition
of tumor response to treatment and may predict clinical
response earlier than RECIST [16, 17]. However, most of these
studies used small sample sizes.
As shown by the results of our internal evaluation using
clay models, CT volumetric analysis is very accurate. This
result is shared by other studies, including those focused
on very small nodules. One study looked specifically at
nodules measuring less than 10mm in diameter and found
that the volume could be measured accurately to within ±3%
[18]. Another study showed that volumetric analysis could
characterize small tumors (5–10mm) dramatically better
than the RECIST criteria.The study detailed the necessity for
volumetric analysis when evaluating changes in lesions of this
size [19].
There were limitations to this study. First, the retrospec-
tive design of this study predisposes it to miscodification bias
as well as selection bias. Second, the study was lacking a vali-
dation cohort.Third, lesionswere limited to lung parenchyma
to allow consistency throughout the study. Fourth, 3mm
slices were used in this study, rather than the 1.5–2mm slices
utilized in many follow-up studies of pulmonary nodules.
The 3mm slices would naturally underestimate overall tumor
volume when compared to thinner slices. Fifth, volumetric
measurementsmay be susceptible to some error that similarly
affects diametric measurements (e.g., change of tumor size
during respiration for pulmonary lesions and change in
tumor enhancement during different contrast phases). Sixth,
performing volumetric analysis is more labor intensive than
diametric analysis. Under repeated trials, a study lesion of
average size (5.37 cm3) could be consistently measured in
less than two minutes. Time trials were conducted with
adherence to the same technical standards used for data
collection: unrushed with attention to detail. A two-minute
measurement time is reasonably low for an average lesion,
but added factors may exacerbate this time (e.g., larger
lesions, multiple lesions, and smaller slices). Labor time is
perhaps the greatest limiting factor toward incorporating
volumetric measurement analysis in practical medicine. Yet,
this limitation is certainly not impassable. Tools that aid in
speeding up this process are already being developed (e.g.,
abovementioned automated methods). Continued research
may offer a better understanding of this technique and
more efficient ways to use it. Seventh, the readers of this
study were senior medical students with limited radiologic
training. Experienced radiologists may be able to perform
measurements with even greater efficiency and speed. Ideally,
a larger number of trained radiologists would be used in this
type study and metastases in many different organ systems
would be assessed, including tumors presenting in areas with
surrounding tissue of similar density.
Future investigation is warranted. The utility of volumet-
ric analysis likely is not limited to lung parenchyma lesions.
Rather, the technique possesses potential for wide applica-
bility in medical science (e.g., evaluation of other anatomic
structures). It would be useful to again compare different
measurement techniques in patients receiving chemother-
apy, evaluating tumor evolution over time. Judging by
the aforementioned inconsistencies, it is unlikely that tumor
diameter will change proportionally with overall tumor size.
Volumetric analysis may be able to detect tumor response
sooner, thereby significantly improving patient outcomes. It
has already been shown that alternativemethods such as PET
scan analysis can save patients from receiving unnecessary
doses of chemotherapy [20]. Volumetric analysis is able to
deliver a much more complete picture of overall tumor size.
It can provide oncologists with additional and more accurate
information to tailor treatment regiments, better equipping
them to treat disease whilst mitigating side effects.
5. Conclusion
This study emphasizes that volumetric measurements can
be accomplished on readily accessible software with highly
reproducible results. It also stresses the limitations of diamet-
ric measurements. An industry standard, diametric analysis
allows the clinical radiologist to make fast and reproducible
measurements. Unfortunately, thismethod offers little insight
into the true size of a tumor. Unsurprisingly, RECIST studies
also document other discrepancies. As imaging technology
advances, so must our associated practices. The utilization
of a volumetric method provides a more comprehensive
and accurate assessment of tumor size, which may alter
clinical decisions. The method boasts promising potential
and may have widespread applicability. Its use deserves
further consideration.
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